You are here

ARPA-H SBIR PHASE II TOPIC ARPA-H 04 INTRA-OPERATIVE CONTRAST AGENTS

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 75N91023C00042
Agency Tracking Number: 75N91023C00042
Amount: $599,180.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: AH04
Solicitation Number: 75N91023R00041
Timeline
Solicitation Year: 2023
Award Year: 2023
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
4640 S MACADAM AVE STE 270
PORTLAND, OR 97239-4232
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 CONNOR BARTH
 (971) 202-0545
 connor@trace-bio.com
Business Contact
 CONNOR BARTH
Phone: (971) 202-0545
Email: connor@trace-bio.com
Research Institution
N/A
Abstract

This project plans to synthesize and characterize novel nerve-specific fluorescence guided surgery (FGS) contrast agents to select a bright, water-soluble lead compound for clinical translation with optimal nerve visualization, functional assessment performance, and clinically relevant pharmacology and toxicology (pharm/tox) profiles for follow-on Investigational New Drug-enabling studies and first-in-human trials.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government